semaglutide fda ban on Compounded GLP-1 Drugs: What to Know Oral Semaglutide Gets FDA Approval
Description
The main safety concern involves compounded GLP-1 medications, which lack FDA oversight for quality and consistency
GLP-1 medications carry a boxed warning that has made many patients uneasy, but the warning is often misunderstood
The C20 fatty diacid moiety is attached to a lysine residue at position 20 via a gamma-glutamate and bis-aminodiethoxyacetyl linker, providing high affinity for albumin binding that prolongs circulating half-life
Twenty percent would be likely to take a new job if it offered such coverage
Pharmaceuticals (Basel) 2019, 12: E8
